These regulations establish the framework for issuing certificates of supplementary protection for pharmaceutical patents in Canada, allowing for extended patent terms to compensate for regulatory approval times, with specific requirements for authorization for sale, patent claims, filing timelines, and fees. They also define eligibility criteria, application procedures, and administrative provisions, including registration, error corrections, and special provisions related to public health emergencies and the Canadaâ€“EU trade agreement.